MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer.
Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, Krebs M, Hartmann E, Puhr M, Müller A, Spahn M, Seitz AK, Frank T, Marouf H, Büchel G, Eckstein M, Kübler H, Eilers M, Saar M, Junker K, Röhrig F, Kneitz B, Rosenfeldt MT, Schulze A.
Kalogirou C, et al. Among authors: linxweiler j.
Nat Commun. 2021 Aug 20;12(1):5066. doi: 10.1038/s41467-021-25325-9.
Nat Commun. 2021.
PMID: 34417456
Free PMC article.